149 related articles for article (PubMed ID: 31409638)
1. Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer.
Yang T; Ren C; Lu C; Qiao P; Han X; Wang L; Wang D; Lv S; Sun Y; Yu Z
Cancer Res; 2019 Oct; 79(20):5233-5244. PubMed ID: 31409638
[TBL] [Abstract][Full Text] [Related]
2. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
[TBL] [Abstract][Full Text] [Related]
3. RING induces cell cycle arrest and apoptosis in human breast cancer cells by regulating the HSF1/MT2A axis.
Liu D; Guo Y; Du Q; Zhu Y; Guo Y
Exp Cell Res; 2023 Dec; 433(1):113795. PubMed ID: 37797799
[TBL] [Abstract][Full Text] [Related]
4. Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model.
Viana PHL; Schvarcz CA; Danics LO; Besztercei B; Aloss K; Bokhari SMZ; Giunashvili N; Bócsi D; Koós Z; Benyó Z; Hamar P
Sci Rep; 2024 Apr; 14(1):8241. PubMed ID: 38589452
[TBL] [Abstract][Full Text] [Related]
5. The proteostasis guardian HSF1 directs the transcription of its paralog and interactor HSF2 during proteasome dysfunction.
Santopolo S; Riccio A; Rossi A; Santoro MG
Cell Mol Life Sci; 2021 Feb; 78(3):1113-1129. PubMed ID: 32607595
[TBL] [Abstract][Full Text] [Related]
6. Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation.
Lu J; Zavorotinskaya T; Dai Y; Niu XH; Castillo J; Sim J; Yu J; Wang Y; Langowski JL; Holash J; Shannon K; Garcia PD
Blood; 2013 Aug; 122(9):1610-20. PubMed ID: 23818547
[TBL] [Abstract][Full Text] [Related]
7. HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity.
Prince TL; Lang BJ; Guerrero-Gimenez ME; Fernandez-Muñoz JM; Ackerman A; Calderwood SK
Cells; 2020 Apr; 9(4):. PubMed ID: 32331382
[TBL] [Abstract][Full Text] [Related]
8. The stress-responsive kinase DYRK2 activates heat shock factor 1 promoting resistance to proteotoxic stress.
Moreno R; Banerjee S; Jackson AW; Quinn J; Baillie G; Dixon JE; Dinkova-Kostova AT; Edwards J; de la Vega L
Cell Death Differ; 2021 May; 28(5):1563-1578. PubMed ID: 33268814
[TBL] [Abstract][Full Text] [Related]
9. Heat shock factor 1 induces cancer stem cell phenotype in breast cancer cell lines.
Wang B; Lee CW; Witt A; Thakkar A; Ince TA
Breast Cancer Res Treat; 2015 Aug; 153(1):57-66. PubMed ID: 26223813
[TBL] [Abstract][Full Text] [Related]
10. HSF1, in association with MORC2, downregulates ArgBP2 via the PRC2 family in gastric cancer cells.
Tong Y; Li Y; Gu H; Wang C; Liu F; Shao Y; Li F
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1104-1114. PubMed ID: 29339121
[TBL] [Abstract][Full Text] [Related]
11. HSF1 Inhibits Antitumor Immune Activity in Breast Cancer by Suppressing CCL5 to Block CD8+ T-cell Recruitment.
Jacobs C; Shah S; Lu WC; Ray H; Wang J; Hockaden N; Sandusky G; Nephew KP; Lu X; Cao S; Carpenter RL
Cancer Res; 2024 Jan; 84(2):276-290. PubMed ID: 37890164
[TBL] [Abstract][Full Text] [Related]
12. Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.
Nair JR; Caserta J; Belko K; Howell T; Fetterly G; Baldino C; Lee KP
Leukemia; 2017 Aug; 31(8):1715-1726. PubMed ID: 28008178
[TBL] [Abstract][Full Text] [Related]
13. Targeted Replacement of HSF1 Phosphorylation Sites at S303/S307 with Alanine Residues in Mice Increases Cell Proliferation and Drug Resistance.
Jin X; Moskophidis D; Mivechi NF
Methods Mol Biol; 2023; 2693():81-94. PubMed ID: 37540428
[TBL] [Abstract][Full Text] [Related]
14. Circadian disruption enhances HSF1 signaling and tumorigenesis in
Pariollaud M; Ibrahim LH; Irizarry E; Mello RM; Chan AB; Altman BJ; Shaw RJ; Bollong MJ; Wiseman RL; Lamia KA
Sci Adv; 2022 Sep; 8(39):eabo1123. PubMed ID: 36170373
[TBL] [Abstract][Full Text] [Related]
15. Heat Shock Factor 1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology.
Gumilar KE; Chin Y; Ibrahim IH; Tjokroprawiro BA; Yang JY; Zhou M; Gassman NR; Tan M
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958341
[TBL] [Abstract][Full Text] [Related]
16. Targeting therapy-resistant prostate cancer via a direct inhibitor of the human heat shock transcription factor 1.
Dong B; Jaeger AM; Hughes PF; Loiselle DR; Hauck JS; Fu Y; Haystead TA; Huang J; Thiele DJ
Sci Transl Med; 2020 Dec; 12(574):. PubMed ID: 33328331
[TBL] [Abstract][Full Text] [Related]
17. Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer.
Levi-Galibov O; Lavon H; Wassermann-Dozorets R; Pevsner-Fischer M; Mayer S; Wershof E; Stein Y; Brown LE; Zhang W; Friedman G; Nevo R; Golani O; Katz LH; Yaeger R; Laish I; Porco JA; Sahai E; Shouval DS; Kelsen D; Scherz-Shouval R
Nat Commun; 2020 Dec; 11(1):6245. PubMed ID: 33288768
[TBL] [Abstract][Full Text] [Related]
18. HSF1 protects cells from cadmium toxicity by governing proteome integrity.
Zhang Y; Liang R; Chen Y; Wang Y; Li X; Wang S; Jin H; Liu L; Tang Z
Ecotoxicol Environ Saf; 2023 Nov; 266():115571. PubMed ID: 37837696
[TBL] [Abstract][Full Text] [Related]
19. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
[No Abstract] [Full Text] [Related]
20. NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer.
Qin G; Wang X; Ye S; Li Y; Chen M; Wang S; Qin T; Zhang C; Li Y; Long Q; Hu H; Shi D; Li J; Zhang K; Zhai Q; Tang Y; Kang T; Lan P; Xie F; Lu J; Deng W
Nat Commun; 2020 Apr; 11(1):1669. PubMed ID: 32245950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
